Philippines

Resilience System

Main menu


You are here

Treatments

Oral antiviral simnotrelvir shows promise for treating mild COVID-19 --study

 

..in the New England Journal of Medicine Chinese researchers have published positive trial results of simnotrelvir, an oral antiviral that can shorten the duration of mild to moderate COVID-19 symptoms.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Long Covid: Change in a handful of blood proteins may pave way to tests and treatment --study

https://www.nbcnews.com/health/health-news/long-covid-cause-study-immune-system-complement-response-rcna134530

Scientists have identified a persistent change in a handful of blood proteins in people with long Covid that indicates that an important part of their immune system remains on high alert for months after an acute infection.

The findings, published Thursday in the journal Science, could help explain what causes the persistent fatigue, brain fog and other debilitating symptoms of long Covid, as well as pave the way for diagnostic tests and potentially, a long-awaited treatment, experts say. 

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

US and UK announce biosecurity alliance to counter pandemics and bioterrorism

 

The UK and US have agreed to work together to counter growing biological threats such as pandemics, antimicrobial resistance and bioterrorism.

The two nations announced a new strategic dialogue on biosecurity on Tuesday.

...

Problem, Solution, SitRep, or ?: 

During the COVID pandemic, care-seeking for heart-related illness fell, with long-term fallout likely --study

Rates of long-term major adverse cardiovascular events (CVEs) fell after the COVID-19 pandemic began in early 2020 and remained lower over the next year among commercially insured New England patients seeking care, and the incidence of congestive heart failure (CHF) and angina (chest pain) remained lower than expected.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Paxlovid Cuts Covid Death Risk. But Useage is Low --studies

As Covid rises again, killing about 1,500 Americans each week, medical researchers are trying to understand why so few people are taking Paxlovid, a medicine that is stunningly effective in preventing severe illness and death from the disease.

ALSO SEE: Less than a third of high-risk COVID outpatients prescribed antivirals, study finds

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Treatments
howdy folks
Page loaded in 0.674 seconds.